Issue

Vol. 34 No. 2 (2022): Vol 34 Issue 2

Copyright (c) 2022 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Synthesis of CEG-AgNPs as a Promising MMPs/COX-2/Bcl-2 Signaling Pathway Modulator in BaP-Induced Lung Carcinoma

https://doi.org/10.14233/ajchem.2022.23456
Ahmed A. Emara
Department of Radiology and Medical Imaging, Faculty of Applied Medical Science, October 6th University, October 6th City, Egypt
Ahmed M. Darwesh
Department of Radiology and Medical Imaging, Faculty of Applied Medical Science, October 6th University, October 6th City, Egypt
Mohamed A. Mostafa
Department of Radiology and Medical Imaging, Faculty of Applied Medical Science, October 6th University, October 6th City, Egypt
Ahmed A. Ahmed
Department of Radiology and Medical Imaging, Faculty of Applied Medical Science, October 6th University, October 6th City, Egypt
Khaled W. Rashad
Department of Radiology and Medical Imaging, Faculty of Applied Medical Science, October 6th University, October 6th City, Egypt
Abdullah M. Said
Department of Radiology and Medical Imaging, Faculty of Applied Medical Science, October 6th University, October 6th City, Egypt
Abdelrahman E. Elsebaay
Department of Radiology and Medical Imaging, Faculty of Applied Medical Science, October 6th University, October 6th City, Egypt
Khaled M. Nasser
Department of Radiology and Medical Imaging, Faculty of Applied Medical Science, October 6th University, October 6th City, Egypt
Abdelrehem S. Amin
Department of Radiology and Medical Imaging, Faculty of Applied Medical Science, October 6th University, October 6th City, Egypt
Mohamed S. Gamil
Department of Radiology and Medical Imaging, Faculty of Applied Medical Science, October 6th University, October 6th City, Egypt
Foad H. Mohamed
Department of Radiology and Medical Imaging, Faculty of Applied Medical Science, October 6th University, October 6th City, Egypt
Mohamed K. Ahmed
Department of Radiology and Medical Imaging, Faculty of Applied Medical Science, October 6th University, October 6th City, Egypt
Diana A. Alshrief
Department of Radiology and Medical Imaging, Faculty of Applied Medical Science, October 6th University, October 6th City, Egypt
Mohammed E. Hassan
Department of Medical Laboratories, Faculty of Applied Medical Sciences, October 6 University, Sixth of October City, Egypt
Zahraa Nassar
Department of Medical Laboratories, Faculty of Applied Medical Sciences, October 6 University, Sixth of October City, Egypt
Amr A. El-Ella
Department of Measurements, Photochemistry and Agriculture Applications. National Institute of Laser Enhanced Science, Cairo University, Giza, Egypt
Mostafa A. Abdel-Maksoud
Department of Radiology and Medical Imaging, Faculty of Medicine, Sudan University of Sciences and Technology, Khartoum, Sudan
Mohammed A. Hussein
Department of Biochemistry, Faculty of Applied Medical Science, October 6th University, October 6th City, Egypt

Corresponding Author(s) : Mohammed A. Hussein

prof.husseinma@o6u.edu.eg

Asian Journal of Chemistry, Vol. 34 No. 2 (2022): Vol 34 Issue 2

Abstract

Cucurbitacins are a class of highly oxidized tetracyclic triterpenoids. It’s hydrophobic properties and poor solubility in water, polymeric micellar systems exhibited improved antitumor efficacy because of a better solubilization and targeting after local and/or systemic administration. The aim of the present work was to evaluate the anticancer activity of CEG-AgNPs against benzo[a]pyren (BaP)-induced lung carcinoma. CEG-AgNPs was prepared, characterized and evaluated for its cytotoxic activity against A549 lung carcinoma cell line. Also, the anticancer activity of CEG-AgNPs (70.25 mg/kg) against BaP-induced lung carcinoma was evaluated in vivo, using 30 adult mice for 43 days. IC50 of CEG-AgNPs against A549 lung carcinoma cell line were approximately 94.47 μg/mL. Administration of BaP (50 mg/kg b.w.) to mice induced lung carcinoma with a significant increase in lung MMP-2, MMP-9, MMP-12, MDA, IL-6 and NF-κB as well as significant decreased in lung CAT, GPx and GSH level. Also, treatment with BaP produced significant increase in lung VEGF-C, COX-2 and Bcl-2 gene expression as compared to control group. Daily oral administration of CEG-AgNPs to mice treated with BaP showed a significant protection against-induced increase in lung MMP-2, MMP-9, MMP-12, MDA, IL-6 and NF-κB levels. The treatment also resulted in a significant increase in lung CAT, GPx and GSH level. In addition, the CEG-AgNPs could inhibit lung VEGF-C, COX-2 and Bcl-2 gene expression as compared to BaP treated mice. The histological and MRI examination showed that a significant normalization has been observed through in CEG-AgNPs treated mice. The biochemical, histological and MRI results showed that CEG-AgNPs have potent anticancer activity against BaP-induced lung carcinoma through modulating multiple cellular behaviours and signaling pathways leading to the suppression of adaptive immune responses.

Keywords

Cucurbitacin-E-glucoside BaP Lung carcinoma Gene expression Antioxidant enzyme Cytokine storm
A. Emara, A., M. Darwesh, A., A. Mostafa, M., A. Ahmed, A., W. Rashad, K., M. Said, A., … A. Hussein, M. (2022). Synthesis of CEG-AgNPs as a Promising MMPs/COX-2/Bcl-2 Signaling Pathway Modulator in BaP-Induced Lung Carcinoma. Asian Journal of Chemistry, 34(2), 289–296. https://doi.org/10.14233/ajchem.2022.23456
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. W.J. Scott, J. Howington, S. Feigenberg, B. Movsas and K. Pisters, Chest, 132, 234S (2007); https://doi.org/10.1378/chest.07-1378
  2. E. Teh, U. Abah, D. Church, W. Saka, D. Talbot, E. Belcher and E. Black, Interact. Cardiovasc. Thorac. Surg., 19, 656 (2014); https://doi.org/10.1093/icvts/ivu206
  3. M.A.Hussein, H.A. El-Gizawy, N.A. Gobba and Y.O. Mosaad, Curr. Pharm. Biotechnol., 18, 677 (2017): https://doi.org/10.2174/1389201018666171004144615
  4. J.P. Vandenbroucke, Int. J. Epidemiol., 38, 1193 (2009); https://doi.org/10.1093/ije/dyp292
  5. R.K. Sticha, E.M. Staretz, M. Wang, H. Liang, M.J. Kenney and S.S. Hecht, Carcinogenesis, 21, 1711 (2000); https://doi.org/10.1093/carcin/21.9.1711
  6. P. Arulazhagan, K. Al-Shekri, Q. Huda, J.J. Godon, J.M. Basahi and D. Jeyakumar, Extremophiles, 21, 163 (2017); https://doi.org/10.1007/s00792-016-0892-0
  7. P. Rajendran, T. Jayakumar, I. Nishigaki, G. Ekambaram, Y. Nishigaki, J. Vetriselvi and D. Sakthisekaran, Int. J. Biomed. Sci., 9, 68 (2013).
  8. H.A. Elgizawy, A.A. Ali and M.A. Hussein, J. Med. Food, 24, 89 (2021); https://doi.org/10.1089/jmf.2019.0286
  9. H.A. El Gizawy, M.A. Hussein and E. Abdel-Sattar, Pharm. Biol., 57, 485 (2019); https://doi.org/10.1080/13880209.2019.1643378
  10. A. Amobi-McCloud, R. Muthuswamy, S. Battaglia, H. Yu, T. Liu, J. Wang, V. Putluri, P.K. Singh, F. Qian, R.Y. Huang, N. Putluri, T. Tsuji, A.A. Lugade, S. Liu and K. Odunsi, Front. Immunol., 12, 678999 (2021); https://doi.org/10.3389/fimmu.2021.678999
  11. B.J. Moyer, I.Y. Rojas, J.S. Kerley-Hamilton, H.F. Hazlett, K.V. Nemani, H.W. Trask, R.J. West, L.E. Lupien, A.J. Collins, C.S. Ringelberg, B. Gimi, W.B. Kinlaw III and C.R. Tomlinson, Toxicol. Appl. Pharmacol., 300, 13 (2016); https://doi.org/10.1016/j.taap.2016.03.011
  12. B.W. Labadie, R. Bao and J.J. Luke, Clin. Cancer Res., 25, 1462 (2019); https://doi.org/10.1158/1078-0432.CCR-18-2882
  13. Y.O. Mosaad, N.A. El Khalik Gobba and M.A. Hussein, Curr. Pharm. Biotechnol., 17, 1189 (2016); https://doi.org/10.2174/1389201017666160922110740
  14. Y. Kong, J. Chen, Z. Zhou, H. Xia, M.-H. Qiu and C. Chen, PLoS One, 9, e103760 (2014); https://doi.org/10.1371/journal.pone.0103760
  15. M. Zhang, C. Sun, X. Shan, X. Yang, J. Li-Ling and Y. Deng, Pancreas, 39, 923 (2010); https://doi.org/10.1097/MPA.0b013e3181ce719e
  16. Q. Zheng, Y. Liu, W. Liu, F. Ma, Y. Zhou, M. Chen, J. Chang, Y. Wang, G. Yang and G. He, Mol. Med. Rep., 10, 89 (2014); https://doi.org/10.3892/mmr.2014.2175
  17. H. Feng, L. Zang, Z.X. Zhao and Q.C. Kan, Cancer Biother. Radiopharm., 29, 210 (2014); https://doi.org/10.1089/cbr.2014.1614
  18. L. Wang, C. Li, Q. Lin, X. Zhang, H. Pan, L. Xu, Z. Shi, D. Ouyang and X. He, Acta Biochim. Biophys. Sin., 47, 459 (2015); https://doi.org/10.1093/abbs/gmv030
  19. A.J. Huh and Y.J. Kwon, J. Control. Rel., 156, 128 (2011); https://doi.org/10.1016/j.jconrel.2011.07.002
  20. S. Pal, Y.K. Tak and J.M. Song, Appl. Environ. Microbiol., 73, 1712 (2007); https://doi.org/10.1128/AEM.02218-06
  21. S. Prabhu and E.K. Poulose, Int. Nano Lett., 2, 32 (2012); https://doi.org/10.1186/2228-5326-2-32
  22. K.S. Lee and M.A. El-Sayed, J. Phys. Chem. B, 110, 19220 (2006); https://doi.org/10.1021/jp062536y
  23. M.S. Abd El-Lat, D.A. Yousif, N.A. Ahmed, G.R. Abd Allah, Y.A. Elbagoury, N.E. El Sayed, H.A. Hassan, B.M. El-hefnawy, A.R. Nageh, E.-S.S. Amer, A.H. Mohamed, N.A. Gobba and M.A. Hussein, Pak. J. Nutr., 20, 37 (2021); https://doi.org/10.3923/pjn.2021.37.45
  24. A. H. Mohamed, M.A. K. Ibrahem, A. A. Elgazar, H. M. Shabib, E. A. Morsy, S. A. Salah, Y. H. Ibrahem, D. M. Mohamed, N. A. Gobba, M. A. Salem, F. M. Ahmed, A. A. Ali and M. A. Hussein, Pak. J. Nutr., 20, 9 (2021); https://doi.org/10.3923/pjn.2021.9.17
  25. M.A. Hussein, H.A. El-gizawy, N.A. Gobba and Y.O. Mosaad, Curr. Pharm. Biotechnol., 18, 677 (2017); https://doi.org/10.2174/1389201018666171004144615
  26. D. Mahor, V. Kumari, K. Vashisht, R. Galgalekar, R.M. Samarth, P.K. Mishra, N. Banerjee, R. Dixit, R. Saluja, S. De and K.C. Pandey, BMC Pulm. Med., 20, 302 (2020); https://doi.org/10.1186/s12890-020-01323-3
  27. S.R. Kim, H.S. Seo, H.S. Choi, S.G. Cho, Y.K. Kim, E.H. Hong, Y.C. Shin and S.G. Ko, Evid. Based Complement. Alternat. Med., 2013, 5350 (2013); https://doi.org/10.1155/2013/975350
  28. S. Kamaraj, P. Anandakumar, S. Jagan, G. Ramakrishnan and T. Devaki, Eur. J. Pharmacol., 649, 320 (2010); https://doi.org/10.1016/j.ejphar.2010.09.017
  29. J. Bartalis and F.T. Halaweish, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 818, 159 (2005); https://doi.org/10.1016/j.jchromb.2004.12.020
  30. S. Tommasi, A. Zheng, J.I. Yoon and A. Besaratinia, Carcinogenesis, 35, 1726 (2014); https://doi.org/10.1093/carcin/bgu026
  31. T. Shimada and Y. Fujii-Kuriyama, Cancer Sci., 95, 1 (2004); https://doi.org/10.1111/j.1349-7006.2004.tb03162.x
  32. G. Bergers, R. Brekken, G. McMahon, T.H. Vu, T. Itoh, K. Tamaki, K. Tanzawa, P. Thorpe, S. Itohara, Z. Werb and D. Hanahan, Nat. Cell Biol., 2, 737 (2000); https://doi.org/10.1038/35036374
  33. C.F. Chantrain, H. Shimada, S. Jodele, S. Groshen, W. Ye, D.R. Shalinsky, Z. Werb, L.M. Coussens and Y.A. DeClerck, Cancer Res., 64, 1675 (2004); https://doi.org/10.1158/0008-5472.CAN-03-0160
  34. R. Roy, J. Yang and M.A. Moses, J. Clin. Oncol., 27, 5287 (2009); https://doi.org/10.1200/JCO.2009.23.5556
  35. H.C. Li, D.C. Cao, Y. Liu, Y.F. Hou, J. Wu, J.S. Lu, G.H. Di, G. Liu, F.M. Li, Z.L. Ou, C. Jie, Z.Z. Shen and Z.M. Shao, Breast Cancer Res. Treat., 88, 75 (2004); https://doi.org/10.1007/s10549-004-1200-8
  36. D. Majumder, R. Debnath and D. Maiti, Life Sci., 260, 118384 (2020); https://doi.org/10.1016/j.lfs.2020.118384
  37. J. Briede, M. Stivriòa, D. Stoldere, E. Bisenieks, J. Uldriíis, J. Poikâns, N. Makarova and G. Duburs, Cell Biochem. Funct., 22, 219 (2004); https://doi.org/10.1002/cbf.1091
  38. H.A. El Gizawy, H.M. Abo-Salem, A.A. Ali and M.A. Hussein, ACS Omega, 6, 20492 (2021); https://doi.org/10.1021/acsomega.1c02340
  39. M.R. Shehata, M.M. Mohamed, M.M. Shoukry, M.A. Hussein and F.M. Hussein, J. Coord. Chem., 68, 1101 (2015); https://doi.org/10.1080/00958972.2015.1007962
  40. M.M. Ghorab, Z.H. Ismail and M. Abdalla, Arzneimittel-Forschung/ Drug Res., 60, 87 (2010); https://doi.org/10.1055/s-0031-1296254
  41. M.A. Hussein, J. Med. Food, 21, 246 (2013); https://doi.org/10.1089/jmf.2012.0183
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 0 Download : 0